Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,615
Closed -$1.91K 2211
2023
Q2
$1.91K Sell
2,615
-5,090
-66% -$4.73K ﹤0.01% 1996
2023
Q1
$5.83K Buy
7,705
+4,905
+175% +$4.55K ﹤0.01% 1920
2022
Q4
$2.69K Buy
+2,800
New +$3.96K ﹤0.01% 1987
2022
Q3
Sell
-1
Closed -$1K 2253
2022
Q2
$1K Buy
+1
New +$4 ﹤0.01% 2090
2020
Q4
Sell
-166
Closed -$1K 2340
2020
Q3
$1K Sell
166
-8
-5% -$71 ﹤0.01% 2197
2020
Q2
$1K Buy
+174
New +$500 ﹤0.01% 2179

Other funds holding VXRT

Federated Hermes's VXRT Position: Q3 2023 in Review

Federated Hermes sold out of Vaxart (VXRT) in Q3 2023, closing a stake of 2,615 shares — an estimated $1.91K sold.

Federated Hermes first reported a position in VXRT in Q2 2020 and held it in 6 quarters. The position peaked at $5.83K in Q1 2023. 96 funds tracked by Wall St. Rank hold VXRT as of Q3 2023.

  • Federated Hermes reported no remaining Vaxart position as of Q3 2023 after selling out during the quarter.
  • Federated Hermes sold 2,615 Vaxart shares in Q3 2023, an estimated $1.91K.
  • Federated Hermes first reported a position in Vaxart in Q2 2020 and held it in 6 quarters.
  • Federated Hermes's Vaxart position peaked at $5.83K in Q1 2023.
  • 96 funds tracked by Wall St. Rank held Vaxart as of Q3 2023.

Based on Federated Hermes's 13F filing for Q3 2023, filed 13 Nov 2023.